• Title of article

    Treatment of Acute Myocardial Infarction by Hepatocyte Growth Factor Gene Transfer: The First Demonstration of Myocardial Transfer of a “Functional” Gene Using Ultrasonic Microbubble Destruction Original Research Article

  • Author/Authors

    Isao Kondo، نويسنده , , Koji Ohmori، نويسنده , , Akira Oshita، نويسنده , , Hiroto Takeuchi، نويسنده , , Sachiko Fuke، نويسنده , , Kaori Shinomiya، نويسنده , , Takahisa Noma، نويسنده , , Tsunetatsu Namba، نويسنده , , Masakazu Kohno، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2004
  • Pages
    10
  • From page
    644
  • To page
    653
  • Abstract
    Objectives We examined whether ultrasonic microbubble destruction (US/MB) enables therapeutic myocardial gene transfer of hepatocyte growth factor (HGF) for acute myocardial infarction (MI). Background Hepatocyte growth factor gene transfer provides cardioprotective effects in MI, which requires direct intramyocardial injection or special vectors. Although US/MB was used in myocardial gene transfer, its feasibility in transfer of a therapeutic gene with non-viral vector remains unknown. Methods In a rat model of acute MI, naked plasmid (pVax1) encoding human HGF (1,500 μg) was infused into the left ventricular (LV) chamber during US/MB (HGF-US/MB) or insonation only (HGF-US) or alone (HGF-alone), while control MI rats received empty pVax1 during US/MB (pVax1-US/MB). For US/MB, transthoracic intermittent insonation with a diagnostic transducer (1.3 MHz) was performed for 2 min at a peak negative pressure of −2,160 kPa during intravenous 20% Optison. Results Baseline risk area was comparable among the groups. Immunohistology seven days after treatment revealed significant myocardial expression of HGF protein only in HGF-US/MB. At three weeks, LV weight in HGF-US/MB (0.89 ± 0.03 g) was significantly lower than those in HGF-alone (1.09 ± 0.08 g), HGF-US (1.04 ± 0.07 g), and pVax1-US/MB (1.04 ± 0.05 g). Moreover, scar size was significantly smaller (16 ± 6% vs. 39 ± 5%, 41 ± 6%, and 40 ± 4% of total myocardial circumferential length, respectively), while capillary density (49 ± 8 vs. 34 ± 5, 37 ± 6, and 36 ± 4 capillaries/high-power field, respectively) and arterial density (37 ± 7 vs. 15 ± 9, 18 ± 4, and 14 ± 11 arterioles/high-power field, respectively) in the risk area were higher in HGF-US/MB than the other groups. Conclusions Ultrasound-mediated microbubble destruction may enable myocardial HGF gene transfer with systemic administration of naked plasmid, which enhances angiogenesis, limits infarction size, and prevents LV remodeling after MI.
  • Keywords
    myocardial infarction , ultrasound , US , MI , MCE , Microbubble , LV , left ventricle/ventricular , myocardial contrast echocardiography , hepatocyte growth factor , MB , HGF , US/MB , ultrasound-mediated microbubble destruction
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2004
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    459338